Working paper Open Access
A small survey of literature about Vitamin D and inhibition and expression of interleukins and tumor necrosis factors. Could Vitamin D have a possible role in Covid-19 Cytokine Release Syndrome? A study of its role when tocilizumab is used exists, and therefore Vitamin D could be considered when tocilizumab is involved in the mitigation of the cytokine storm. However, another question also exists and it is the following. Might Vitamin D induce antimicrobial peptides to reduce SARS-CoV-2 replication?
Name | Size | |
---|---|---|
vitamin-D.pdf
md5:84eff5dd1e7a04490c9924def7c6a23c |
129.6 kB | Download |
All versions | This version | |
---|---|---|
Views | 577 | 577 |
Downloads | 156 | 156 |
Data volume | 20.2 MB | 20.2 MB |
Unique views | 548 | 548 |
Unique downloads | 143 | 143 |